Interactions and associations of paraoxonase gene cluster polymorphisms with myocardial infarction in a Pakistani population

Clinical Genetics

Volumn 71, Issue 3, 2007, Pages 238-244

  Saeed, M ^a,b   Perwaiz Iqbal, M ^a   Yousuf, F A ^a   Perveen, S ^a   Shafiq, M ^a   Sajid, J ^a,c   Frossard, P M ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

^b NORTHWESTERN UNIVERSITY   (United States)

^c Royal Edward Infirmary   (United Kingdom)

Author keywords

Coronary artery disease; Epistasis; Gene environment; Interaction; Paraoxonase; Smoking

Indexed keywords

ARYLDIALKYLPHOSPHATASE;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CIGARETTE SMOKING; CLUSTER ANALYSIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; ELECTROCARDIOGRAPHY; ENZYME POLYMORPHISM; FEMALE; GENE CLUSTER; GENE FREQUENCY; GENE LOCUS; GENETIC PREDISPOSITION; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HAPLOTYPE; HEART INFARCTION; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PAKISTAN; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ARYLDIALKYLPHOSPHATASE; CASE-CONTROL STUDIES; EPISTASIS, GENETIC; FEMALE; GENETICS, POPULATION; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MULTIGENE FAMILY; MYOCARDIAL INFARCTION; PAKISTAN; POLYMORPHISM, GENETIC;

EID: 33847320595     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2007.00753.x     Document Type: Article

References (25)

1. Yusuf S, Hawken S, Ounpuu S et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 2004: 364 (9438): 937-952.
2. Costa LG, Cole TB, Furlong CE. Polymorphisms of paraoxonase (PON1) and their significance in clinical toxicology of organophosphates. J Toxicol Clin Toxicol 2003: 41 (1): 37-45.
3. Clendenning JB, Humbert R, Green ED et al. Structural organization of the human PON1 gene. Genomics 1996: 35 (3): 586-589.
4. Reddy ST, Wadleigh DJ, Grijalva V et al. Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids. Arterioscler Thromb Vasc Biol 2001: 21 (4): 542-547.
5. Ng CJ, Wadleigh DJ, Gangopadhyay A et al. Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein. J Biol Chem 2001: 276 (48): 44444-44449.
6. Watson AD, Berliner JA, Hama SY et al. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest 1995: 96 (6): 2882-2891.
7. Humbert R, Adler DA, Disteche CM et al. The molecular basis of the human serum paraoxonase activity polymorphism. Nat Genet 1993: 3 (1): 73-76.
8. Wheeler JG, Keavney BD, Watkins H et al. Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: Meta-analysis of 43 studies. Lancet 2004: 363 (9410): 689-695.
9. Chen Q, Reis SE, Kammerer CM et al. Association between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. Am J Hum Genet 2003: 72 (1): 13-22.
10. Ranade K, Kirchgessner TG, Iakoubova OA et al. Evaluation of the paraoxonases as candidate genes for stroke: Gln192Arg polymorphism in the paraoxonase 1 gene is associated with increased risk of stroke. Stroke 2005: 36 (11): 2346-2350.
11. McKeigue PM, Marmot MG. Mortality from coronary heart disease in Asian communities in London. BMJ 1988: 297: 903.
12. Nishtar S. Prevention of coronary heart disease. Lancet 2002: 360: 1015-1018.
13. Saleheen D, Frossard P. CAD risk factors and acute myocardial infarction in Pakistan. Acta Cardiol 2004: 59 (4): 417-424.
14. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning, a laboratory manual, 2nd edn. Cold Spring, New York: Cold Spring Harbor Laboratory Press, 1989.
15. Wang X, Fan Z, Huang J et al. Extensive association analysis between polymorphisms of PON gene cluster with coronary heart disease in Chinese Han population. Arterioscler Thromb Vasc Biol 2003: 23 (2): 328-334.
16. Zhao JH, Curtis D, Sham PC. Model-free analysis and permutation test for allelic associations. Hum Hered 2000: 50: 133-139.
17. Barrett JC, Fry B, Maller J et al. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005: 21 (2): 263-265.
18. Freitas A. Understanding the crucial role of attribute interaction in data mining. Artif Intel Rev 2001: 16: 177-199.
19. Ritchie MD, Hahn LW, Moore JH. Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity. Genet Epidemiol 2003: 24 (2): 150-157.
20. Ma DQ, Whitehead PL, Menold MM et al. Identification of significant association and gene-gene interaction of GABA receptor subunit genes in autism. Am J Hum Genet 2005: 77 (3): 377-388.
21. Hahn LW, Ritchie MD, Moore JH. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics. 2003: 19 (3): 376-382.
22. Moore JH. The ubiquitous nature of epistasis in determining susceptibility to common human diseases. Hum Hered 2003: 56 (1-3): 73-82.
23. Moore JH, Williams SM. New strategies for identifying gene-gene interactions in hypertension. Ann Med 2002: 34 (2): 88-95.
24. Iqbal MP, Shifiq M, Mehboobali N et al. Variability in lipid profile in Pakistani patients with acute myocardial infarction. J Pak Med Assoc 2004: 54 (11): 544-549.
25. Ghaffar A, Reddy KS, Singhi M. Burden of non-communicable diseases in South Asia. BMJ 2004: 328: 807-810.